Şerif Şentürk
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 4
- Hepatology top 5%
- Aging top 10%
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 6
- CRISPR and Genetic Engineering 5
- RNA Interference and Gene Delivery 4
- TGF-β signaling in diseases 4
-
- Telomeres, Telomerase, and Senescence 7
-
- Cancer Mechanisms and Therapy 4
-
- Bladder and Urothelial Cancer Treatments 4
- Co-authors
- Mehmet ÖztürkKamil Can AkçalıEsra ErdalÖzge Gürsoy-YüzügüllüHaluk YuzugulluRaffaella SordellaDebjani PalNuri Öztürk
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Nature Communications (1 paper)PLoS ONE (1 paper)
- Partner nations
- TürkiyeUnited StatesFrance
In The Last Decade
Şerif Şentürk
37 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 93
- Cancer Research 246
- Hepatology 125
- Business and International Management 28
- Aging 23
- Molecular Biology 796
Countries citing papers authored by Şerif Şentürk
This map shows the geographic impact of Şerif Şentürk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Şerif Şentürk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Şerif Şentürk more than expected).
Fields of papers citing papers by Şerif Şentürk
This network shows the impact of papers produced by Şerif Şentürk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Şerif Şentürk. The network helps show where Şerif Şentürk may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Şerif Şentürk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 8 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 1 | |
| 10 | 2022 | 4 | |
| 11 | 2021 | 9 | |
| 12 | 2021 | 4 | |
| 13 | 2021 | 35 | |
| 14 | 2019 | 55 | |
| 15 | 2017 | 133 | |
| 16 | 2015 | 64 | |
| 17 | 2013 | 24 | |
| 18 | 2010 | 19 | |
| 19 | 2009 | 173 | |
| 20 | 2008 | 66 |
About Şerif Şentürk
Şerif Şentürk is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 38 papers that have together received 1.2k indexed citations. Recurring topics across this work include Telomeres, Telomerase, and Senescence (7 papers), Epigenetics and DNA Methylation (6 papers), CRISPR and Genetic Engineering (5 papers), Cancer Mechanisms and Therapy (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Bladder and Urothelial Cancer Treatments (4 papers), RNA Interference and Gene Delivery (4 papers) and TGF-β signaling in diseases (4 papers). The work is most often cited by research in Cancer Research (246 citations), Hepatology (125 citations) and Business and International Management (28 citations). Şerif Şentürk has collaborated with scholars based in Türkiye, United States and France. Frequent co-authors include Mehmet Öztürk, Kamil Can Akçalı, Esra Erdal, Özge Gürsoy-Yüzügüllü, Haluk Yuzugullu, Raffaella Sordella, Debjani Pal, Nuri Öztürk, Nitin H. Shirole and Dawid G. Nowak. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.